Literature DB >> 3928031

Oral cholestyramine increases elimination of warfarin after overdose.

S Renowden, D Westmoreland, J P White, P A Routledge.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3928031      PMCID： PMC1416500          DOI： 10.1136/bmj.291.6494.513

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Treatment of phenprocoumon intoxication with cholestyramine.

Authors:  T Meinertz; M J Gilfrich; R Bork; E Jahnchen
Journal:  Br Med J       Date:  1977-08-13

2.  Vitamin K1 disposition and therapy of warfarin overdose.

Authors:  T D Bjornsson; T F Blaschke
Journal:  Lancet       Date:  1978-10-14       Impact factor: 79.321

3.  Plasma disposition of vitamin K1 in relation to anticoagulant poisoning.

Authors:  B K Park; A K Scott; A C Wilson; B P Haynes; A M Breckenridge
Journal:  Br J Clin Pharmacol       Date:  1984-11       Impact factor: 4.335

4.  Enhanced elimination of warfarin during treatment with cholestyramine.

Authors:  E Jähnchen; T Meinertz; H J Gilfrich; F Kersting; U Groth
Journal:  Br J Clin Pharmacol       Date:  1978-05       Impact factor: 4.335

5.  High-pressure liquid chromatographic analysis of drugs in biological fluids I. Warfarin.

Authors:  T D Bjornsson; T F Blaschke; P J Meffin
Journal:  J Pharm Sci       Date:  1977-01       Impact factor: 3.534
  5 in total
  7 in total

1.  Effects of resins and activated charcoal on the absorption of digoxin, carbamazepine and frusemide.

Authors:  P J Neuvonen; K Kivistö; E L Hirvisalo
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

2.  Enhanced elimination of piroxicam by administration of activated charcoal or cholestyramine.

Authors:  D G Ferry; L R Gazeley; W J Busby; D M Beasley; I R Edwards; A J Campbell
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

3.  Warfarin overdose: a 25-year experience.

Authors:  Michael Levine; Anthony F Pizon; Angela Padilla-Jones; Anne-Michelle Ruha
Journal:  J Med Toxicol       Date:  2014-06

4.  Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids.

Authors:  Douglas L Feinstein; Daniel G Nosal; Swetha Ramanathan; Jifang Zhou; Luying Chen; Ronald C Hershow; Richard B van Breemen; Erik Wright; John W Hafner; Israel Rubinstein
Journal:  Clin Toxicol (Phila)       Date:  2019-11-18       Impact factor: 4.467

Review 5.  Clinically significant drug interactions with the oral anticoagulants.

Authors:  M D Freedman; A G Olatidoye
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

Review 6.  Clinical pharmacokinetic considerations in the control of oral anticoagulant therapy.

Authors:  H G Shetty; A G Fennerty; P A Routledge
Journal:  Clin Pharmacokinet       Date:  1989-04       Impact factor: 6.447

7.  Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults.

Authors:  P Asiedu; T Moulton; C B Blum; E Roldan; N J Lolacono; J H Graziano
Journal:  Environ Health Perspect       Date:  1995 Jul-Aug       Impact factor: 9.031
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.